GlassScriptPhysician profile
David Okolica
NPI 1518148774
$11,541.08
in general payments reported to CMS, 2019-2025
9 companies · $113 in 2025
The $113 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,877 · 2020: $5,173 · 2022: $48.82 · 2023: $330 · 2025: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $238 · Food and Beverage: $205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $238.07 |
| Food and Beverage | $204.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,190.00 | 2019-2023 | Da Vinci Surgical System |
| Amarin Pharma, INC. | $80.33 | 2019 | |
| Smith+Nephew, INC. | $77.69 | 2025 | Allevyn Heel 10.5cm X 13.5cm Ctn 5, Collagenase Santyl, "Acticoat 4"" X 4""" |
| Bayer Healthcare Pharmaceuticals INC. | $67.85 | 2019 | |
| Medtronic, INC. | $48.82 | 2022 | |
| Organogenesis INC. | $21.30 | 2019 | |
| Ethicon US, LLC | $19.86 | 2020 | |
| Lifenet Health | $18.71 | 2025 | Theragenesis Wound Matrix |
| Novo Nordisk INC | $16.52 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Okolica listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.